|
|
|
| Effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly |
| WU Mengyi, HU Jinsong, HUANG Shuang, HUANG Yuanxiu
|
| Changsha Center for Disease Control and Prevention (Changsha Municipal Bureau of Comprehensive Health Supervision and Law Enforcement), Changsha, Hunan 410004, China |
|
|
|
|
Abstract Objective To analyze the effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly, so as to provide evidence for early identification, high-risk population screening and precise intervention of dyslipidemia among the elderly. Methods Based on the National Basic Public Health Service Program, the elderly aged ≥65 years in Changsha City were selected as study participants. Data on gender, age, body mass index, waist circumference, total cholesterol, triglycerides and serum uric acid were collected through the Hunan Provincial Primary Health Information System. A multivariable logistic regression model was used to analyze the effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly. The Excel sheet compiled by Andersson et al. was used to calculate the relative excess risk due to interaction (RERI), the attributable proportion due to interaction (AP) and the synergy index (SI). Results A total of 1 755 participants were included, including 833 males (47.46%) and 922 females (52.54%). The median age was 73.00 (interquartile range, 9.00) years. A total of 597 participants had overweight and obesity (34.02%), 583 had central obesity (33.22%), and 323 had hyperuricemia (18.40%). Dyslipidemia was detected in 663 participants, with a detection rate of 37.78%. Multivariable logistic regression analysis showed that overweight and obesity (OR=2.734, 95%CI: 2.207-3.386), central obesity (OR=2.665, 95%CI: 2.152-3.301), hyperuricemia (OR=2.459, 95%CI: 1.910-3.165), overweight and obesity combined with hyperuricemia (OR=5.417, 95%CI: 3.741-7.843) and central obesity combined with hyperuricemia (OR=5.307, 95%CI: 3.633-7.751) were statistically associated with a higher risk of dyslipidemia among the elderly. Interaction analysis showed that there was an additive interaction between overweight and obesity and hyperuricemia on dyslipidemia among the elderly (RERI=1.568, 95%CI: 0.371-2.765; AP=0.289, 95%CI: 0.068-0.510; SI=1.550, 95%CI: 1.135-2.116), and an additive interaction between central obesity and hyperuricemia on dyslipidemia among the elderly (RERI=1.303, 95%CI: 0.115-2.491; AP=0.246, 95%CI: 0.022-0.470; SI=1.434, 95%CI: 1.045-1.968). Conclusion Interaction effects of overweight and obesity or central obesity comorbid with hyperuricemia on dyslipidemia among the elderly were observed and may increase the risk of dyslipidemia.
|
|
Received: 28 July 2026
Revised: 27 August 2026
Published: 27 October 2026
|
|
|
|
|
|
[1] Pirillo A,Casula M,Olmastroni E,et al.Global epidemiology of dyslipidaemias[J].Nat Rev Cardiol,2021,18(10):689-700. [2] 国家心血管病中心.中国心血管健康与疾病报告2019[M].北京:科学出版社,2020. [3] 陈曾丽,蒋运兰,卢宇彤,等.中国老年人血脂异常患病率的Meta分析[J].中国全科医学,2022,25(1):115-121. [4] 陶寄,盛敏阳,许云峰,等.海宁市居民血脂异常的影响因素分析[J].预防医学,2022,34(8):821-825. [5] 贾瀚璐,沈天然,李钰,等.老年人体质指数和血脂异常的剂量反应关系研究[J].现代预防医学,2023,50(13):2337-2343. [6] WS/T 428—2013 成人体重判定[S]. [7] 中华医学会内分泌学分会.高尿酸血症和痛风治疗的中国专家共识[J].中华内分泌代谢杂志,2013,29(11):913-920. [8] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等.血脂异常基层诊疗指南(实践版·2019)[J].中华全科医师杂志,2019,18(5):417-421. [9] Andersson T,Alfredsson L,Källberg H,et al.Calculating measures of biological interaction[J].Eur J Epidemiol,2005,20(7):575-579. [10] 王盛书,杨姗姗,李皓炜,等.北京城乡老年人群血脂异常流行状况及其与全因死亡的关联研究[J].中国慢性病预防与控制,2024,32(1):8-14. [11] 周阳,顾忠凯,杨施黛琳,等.2024年上海市奉贤区某社区≥60岁老年人慢性病及共病检出情况分析[J].江苏卫生保健,2026,28(3):239-241. [12] 孙静文,赖龙胜,林玉凤,等.厦门市某社区65岁及以上老年人健康体检结果分析[J].中国初级卫生保健,2025,39(10):12-15. [13] 李秋佳,江秀,谢天.成都市郫都区11万常住老年人血脂异常患病率及影响因素分析[J].现代预防医学,2025,52(11):2107-2112. [14] 王岩,王应昉,陈凤,等.铁西区老年人血脂异常及影响因素分析[J].预防医学,2020,32(9):920-922. [15] 赵晶晶,曹亚景,李玫,等.肥胖与高尿酸血症的交互作用对血脂异常患病的影响[J].中国慢性病预防与控制,2023,31(12):922-926. [16] Nussbaumerova B,Rosolova H.Obesity and dyslipidemia[J].Curr Atheroscler Rep,2023,25(12):947-955. [17] Choi Y J,Shin H S,Choi H S,et al.Uric acid induces fat accumulation via generation of endoplasmic reticulum stress and SREBP-1c activation in hepatocytes[J].Lab Investig,2014,94(10):1114-1125. [18] Item F,Konrad D.Visceral fat and metabolic inflammation:the portal theory revisited[J].Obes Rev,2012,13(Suppl. 2):30-39. [19] Ali N.Serum uric acid as a mediator of insulin resistance:molecular mechanisms and metabolic pathways[J/OL].Endocrino Diabet & Metabol,2026,9[2026-08-27].https://doi.org/10.1002/edm2.70163. |
|
|
|